Indian drug controller establishes timelines for handling applications
This article was originally published in SRA
Executive Summary
The Drug Controller General of India has issued targeted timelines for responding to various applications submitted by drug and medical device companies1. The move is expected to establish greater transparency and consistency in the regulator’s interactions with the industry.
You may also be interested in...
Hunt On For New Chair Of UK Regulator
Whoever takes over as chair of the Medicines and Healthcare products Regulatory Agency will play a key role in its plans to deliver a program of “ambitious business change.”
ICH Syncs Reproductive Toxicity Guidance With Current Science
The International Council for Harmonisation has replaced its 1993 guideline on reproductive toxicity studies with an updated version.
Hunt On For New Chair Of UK Regulator
Whoever takes over as chair of the Medicines and Healthcare products Regulatory Agency will play a key role in its plans to deliver a program of “ambitious business change.”
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: